{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T03:21:26Z","timestamp":1790392886178,"version":"4.1.0"},"reference-count":29,"publisher":"The Company of Biologists","issue":"5","license":[{"start":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T00:00:00Z","timestamp":1599091200000},"content-version":"vor","delay-in-days":477,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,5,15]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n               <jats:p>Iron overload in the liver causes oxidative stress and inflammation, which result in organ dysfunction, making it a risk factor for non-alcoholic steatohepatitis (NASH) and hepatocellular carcinoma. We aimed to evaluate the effect of dietary iron restriction on disease progression in rats fed a choline-deficient L-amino acid-defined (CDAA) diet. Male F344 rats were fed a choline-sufficient amino acid-defined (control) diet, a CDAA diet or an iron-restricted CDAA diet for 4, 8 and 12\u2005weeks. At each time point, hepatic iron levels, oxidative stress, inflammation and fibrosis were evaluated by immunohistochemistry. The iron-restricted CDAA diet significantly decreased serum iron levels for 12\u2005weeks compared with the CDAA diet. Histological analysis confirmed that feeding with the CDAA diet induced hepatic iron overload and that this was associated with oxidative stress (number of 8-hydroxydeoxyguanosine-positive cells), inflammation (CD68 positive area) and fibrosis (Sirius Red positive area). Iron restriction with the CDAA diet significantly led to a reduction in the hepatic iron levels, oxidative stress, inflammation and fibrosis. Therefore, dietary iron restriction could be a useful therapeutic approach for NASH patients with hepatic iron overload.<\/jats:p>","DOI":"10.1242\/bio.040519","type":"journal-article","created":{"date-parts":[[2019,5,16]],"date-time":"2019-05-16T18:05:15Z","timestamp":1558029915000},"source":"Crossref","is-referenced-by-count":13,"title":["Dietary iron restriction leads to a reduction in hepatic fibrosis in a rat model of non-alcoholic steatohepatitis"],"prefix":"10.1242","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8901-3796","authenticated-orcid":false,"given":"Naomichi","family":"Abe","sequence":"first","affiliation":[{"name":"Sohyaku. Innovative Research Division, Mitsubishi Tanabe Pharma Corporation, 2-2-50, Kawagishi, Toda-shi, Saitama 335-8505, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuma","family":"Tsuchida","sequence":"additional","affiliation":[{"name":"Sohyaku. Innovative Research Division, Mitsubishi Tanabe Pharma Corporation, 2-2-50, Kawagishi, Toda-shi, Saitama 335-8505, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin-Ichiro","family":"Yasuda","sequence":"additional","affiliation":[{"name":"Sohyaku. Innovative Research Division, Mitsubishi Tanabe Pharma Corporation, 2-2-50, Kawagishi, Toda-shi, Saitama 335-8505, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kozo","family":"Oka","sequence":"additional","affiliation":[{"name":"Sohyaku. Innovative Research Division, Mitsubishi Tanabe Pharma Corporation, 2-2-50, Kawagishi, Toda-shi, Saitama 335-8505, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"237","published-online":{"date-parts":[[2019,5,16]]},"reference":[{"key":"2021042423281264200_BIO040519C1","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1056\/NEJM199912233412607","article-title":"Disorders of iron metabolism","volume":"341","author":"Andrews","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"2021042423281264200_BIO040519C2","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1002\/hep.1840110122","article-title":"The pathology of hepatic iron overload: a free radical--mediated process?","volume":"11","author":"Bacon","year":"1990","journal-title":"Hepatology"},{"key":"2021042423281264200_BIO040519C3","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/hep.24330","article-title":"Diagnosis and management of hemochromatosis: 2011 practice guideline by the American Association for the Study of Liver Diseases","volume":"54","author":"Bacon","year":"2011","journal-title":"Hepatology"},{"key":"2021042423281264200_BIO040519C4","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1002\/hep.24127","article-title":"Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings","volume":"53","author":"Brunt","year":"2011","journal-title":"Hepatology"},{"key":"2021042423281264200_BIO040519C5","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/S0021-9258(18)48474-8","article-title":"8-Hydroxyguanine, an abundant form of oxidative DNA damage, causes G----T and A----C substitutions","volume":"267","author":"Cheng","year":"1992","journal-title":"J. Biol. Chem."},{"key":"2021042423281264200_BIO040519C6","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.jhep.2010.03.001","article-title":"EASL clinical practice guidelines for HFE hemochromatosis","volume":"53","author":"European Association for the Study of the Liver","year":"2010","journal-title":"J. Hepatol."},{"key":"2021042423281264200_BIO040519C7","doi-asserted-by":"publisher","first-page":"2448","DOI":"10.1111\/j.1572-0241.2001.04052.x","article-title":"Hyperferritinemia, iron overload, and multiple metabolic alterations identify patients at risk for nonalcoholic steatohepatitis","volume":"96","author":"Fargion","year":"2001","journal-title":"Am. J. Gastroenterol."},{"key":"2021042423281264200_BIO040519C8","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/S0016-5085(98)70482-2","article-title":"Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis","volume":"114","author":"George","year":"1998","journal-title":"Gastroenterology"},{"key":"2021042423281264200_BIO040519C9","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1002\/hep.27774","article-title":"Increased duodenal iron absorption through up-regulation of divalent metal transporter 1 from enhancement of iron regulatory protein 1 activity in patients with nonalcoholic steatohepatitis","volume":"62","author":"Hoki","year":"2015","journal-title":"Hepatology"},{"key":"2021042423281264200_BIO040519C10","doi-asserted-by":"publisher","first-page":"G1094","DOI":"10.1152\/ajpgi.00365.2010","article-title":"Combination treatment of angiotensin II type I receptor blocker and new oral iron chelator attenuates progression of nonalcoholic steatohepatitis in rats","volume":"300","author":"Kaji","year":"2011","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"2021042423281264200_BIO040519C11","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/S0168-8278(01)00171-4","article-title":"In situ detection of oxidative DNA damage, 8-hydroxydeoxyguanosine, in chronic human liver disease","volume":"35","author":"Kitada","year":"2001","journal-title":"J. Hepatol."},{"key":"2021042423281264200_BIO040519C12","doi-asserted-by":"publisher","first-page":"S79","DOI":"10.1016\/j.gastro.2004.09.019","article-title":"Iron, hemochromatosis, and hepatocellular carcinoma","volume":"127","author":"Kowdley","year":"2004","journal-title":"Gastroenterology"},{"key":"2021042423281264200_BIO040519C13","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1002\/hep.24706","article-title":"Serum ferritin is an independent predictor of histologic severity and advanced fibrosis in patients with nonalcoholic fatty liver disease","volume":"55","author":"Kowdley","year":"2012","journal-title":"Hepatology"},{"key":"2021042423281264200_BIO040519C14","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.1002\/hep.26238","article-title":"Hepatic reticuloendothelial system cell iron deposition is associated with increased apoptosis in nonalcoholic fatty liver disease","volume":"57","author":"Maliken","year":"2013","journal-title":"Hepatology"},{"key":"2021042423281264200_BIO040519C15","doi-asserted-by":"publisher","first-page":"833","DOI":"10.3324\/haematol.2012.066845","article-title":"Non-transfusion-dependent thalassemias","volume":"98","author":"Musallam","year":"2013","journal-title":"Haematologica"},{"key":"2021042423281264200_BIO040519C16","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1111\/j.1572-0241.2005.41287.x","article-title":"Duration of hepatic iron exposure increases the risk of significant fibrosis in hereditary hemochromatosis: a new role for magnetic resonance imaging","volume":"100","author":"Olynyk","year":"2005","journal-title":"Am. J. Gastroenterol."},{"key":"2021042423281264200_BIO040519C17","doi-asserted-by":"publisher","first-page":"R311","DOI":"10.1152\/ajpregu.00735.2007","article-title":"Attenuation of acute and chronic liver injury in rats by iron-deficient diet","volume":"294","author":"Otogawa","year":"2008","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"2021042423281264200_BIO040519C18","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/978-1-4615-0593-8_2","article-title":"Mechanism of iron toxicity","volume":"509","author":"Pietrangelo","year":"2002","journal-title":"Adv. Exp. Med. Biol."},{"key":"2021042423281264200_BIO040519C19","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.jhep.2008.11.011","article-title":"Iron in NASH, chronic liver diseases and HCC: how much iron is too much?","volume":"50","author":"Pietrangelo","year":"2009","journal-title":"J. Hepatol."},{"key":"2021042423281264200_BIO040519C20","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.jhep.2016.01.037","article-title":"Mechanisms of iron hepatotoxicity","volume":"65","author":"Pietrangelo","year":"2016","journal-title":"J. Hepatol."},{"key":"2021042423281264200_BIO040519C21","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1023\/A:1026661508553","article-title":"Iron chelator deferoxamine reduces preneoplastic lesions in liver induced by choline-deficient L-amino acid-defined diet in rats","volume":"44","author":"Sakaida","year":"1999","journal-title":"Dig. Dis. Sci."},{"key":"2021042423281264200_BIO040519C23","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/S0168-8278(02)00331-8","article-title":"Serum thioredoxin levels as a predictor of steatohepatitis in patients with nonalcoholic fatty liver disease","volume":"38","author":"Sumida","year":"2003","journal-title":"J. Hepatol."},{"key":"2021042423281264200_BIO040519C24","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1111\/j.1872-034X.2008.00442.x","article-title":"Role of hepatic iron in non-alcoholic steatohepatitis","volume":"39","author":"Sumida","year":"2009","journal-title":"Hepatol. Res."},{"key":"2021042423281264200_BIO040519C25","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1007\/s00535-012-0739-0","article-title":"Increased hepatic oxidative DNA damage in patients with nonalcoholic steatohepatitis who develop hepatocellular carcinoma","volume":"48","author":"Tanaka","year":"2013","journal-title":"J. Gastroenterol."},{"key":"2021042423281264200_BIO040519C26","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1111\/j.1572-0241.2007.01192.x","article-title":"Iron depletion by phlebotomy improves insulin resistance in patients with nonalcoholic fatty liver disease and hyperferritinemia: evidence from a case-control study","volume":"102","author":"Valenti","year":"2007","journal-title":"Am. J. Gastroenterol."},{"key":"2021042423281264200_BIO040519C27","doi-asserted-by":"publisher","first-page":"e48804","DOI":"10.1371\/journal.pone.0048804","article-title":"The A736V TMPRSS6 polymorphism influences hepatic iron overload in nonalcoholic fatty liver disease","volume":"7","author":"Valenti","year":"2012","journal-title":"PLoS ONE"},{"key":"2021042423281264200_BIO040519C28","doi-asserted-by":"publisher","first-page":"3002","DOI":"10.3748\/wjg.v20.i11.3002","article-title":"A randomized trial of iron depletion in patients with nonalcoholic fatty liver disease and hyperferritinemia","volume":"20","author":"Valenti","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"2021042423281264200_BIO040519C29","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1111\/j.1440-1746.2006.04548.x","article-title":"Restriction of dietary calories, fat and iron improves non-alcoholic fatty liver disease","volume":"22","author":"Yamamoto","year":"2007","journal-title":"J. Gastroenterol. Hepatol."},{"key":"2021042423281264200_BIO040519C30","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1093\/carcin\/13.7.1227","article-title":"Inhibitory effect of dietary iron deficiency on inductions of putative preneoplastic lesions as well as 8-hydroxydeoxyguanosine in DNA and lipid peroxidation in the livers of rats caused by exposure to a choline-deficient L-amino acid defined diet","volume":"13","author":"Yoshiji","year":"1992","journal-title":"Carcinogenesis"}],"container-title":["Biology Open"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.logists.com\/bio\/bio\/article-pdf\/doi\/10.1242\/bio.040519\/1829504\/bio040519.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/journals.logists.com\/bio\/bio\/article-pdf\/doi\/10.1242\/bio.040519\/1829504\/bio040519.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,24]],"date-time":"2021-04-24T23:28:17Z","timestamp":1619306897000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.biologists.com\/bio\/article\/8\/5\/bio040519\/1494\/Dietary-iron-restriction-leads-to-a-reduction-in"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,15]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5,15]]}},"URL":"https:\/\/doi.org\/10.1242\/bio.040519","relation":{},"ISSN":["2046-6390"],"issn-type":[{"value":"2046-6390","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,15]]},"article-number":"bio040519"}}